Domov › Nemalicelični pljučni rak › Montana › Bozeman

Klinične študije za Nemalicelični pljučni rak v Bozeman, MT

10 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Bozeman in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Vključevanje udeležencevFaza 3

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3

Bozeman Health Deaconess Hospital - Bozeman Health Cancer Center, Bozeman
Bozeman Health Deaconess Hospital - Bozeman Health Clinical Research, Bozeman
Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Vključevanje udeležencevFaza 2

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT03191149

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2

Bozeman Health Deaconess Hospital, Bozeman

18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Vključevanje udeležencevOpazovalna študija

Bozeman Health Deaconess Hospital, Bozeman

Starost 18 in več · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06418204

Študije za Nemalicelični pljučni rak v drugih mestih

Druge študije v Bozeman

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.